Date of publication: December 3, 2020

Objectives:

  • To synthesize information on clinical effectiveness and safety of HFNC among COVID-19 patients with acute hypoxemic respiratory failure
  • To synthesize information on clinical guidelines and current positions of HTA agencies on the use of HFNC among COVID-19 patients with acute hypoxemic respiratory failure
  • To determine the resource requirements and associated costs on the use of HFNC among COVID-19 patients with acute hypoxemic respiratory failure
  • To determine the ethical and social issues on the use of HFNC among COVID-19 patients with acute hypoxemic respiratory failure

Evidence summary: http://bit.ly/2YbjYwl

Rapid review: http://bit.ly/3pe9sAm